Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 4/2018

22.12.2017 | Original Article

Incidental Gallbladder Carcinoma Discovered after Laparoscopic Cholecystectomy: Identifying Patients Who will Benefit from Reoperation

verfasst von: Pietro Addeo, Leonardo Centonze, Andrea Locicero, François Faitot, Hissam Jedidi, Emanuele Felli, Pascal Fuchshuber, Philippe Bachellier

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Despite an early radical reoperation, recurrence and poor survival are observed in up to 40% of patients with an incidentally discovered gallbladder carcinoma (I-GBC) after undergoing a laparoscopic cholecystectomy (LC). This study seeks to identify prognostic factors after re-I-GBC resection.

Methods

A retrospective review of a prospectively maintained patient database with patients who were undergoing resection for I-GBC from January 1995 to March 2017 was performed. Prognostic factors for survival were assessed by multivariate Cox analysis.

Results

There were 50 consecutive patients (median age 64 years; range 38–82) undergoing reoperation 45 ± 30 days after LC. Re-resection entailed a major hepatectomy in five patients (10%) and lymphadenectomy in all patients. Ninety-day morbidity and mortality were 22 and 2%, respectively. Lymph node (LN) involvement was present in 24 (48%) patients with a mean of 5.79 ± 14.4 LN+. Median overall survival was 40 months with 1-, 3-, 5- and 10-year survival rates of 80, 50, 41 and 36%, respectively. Independent risk factors for overall survival were T3 tumours (HR = 7.58; 95% confidence intervals (CI), 2.41–23.83.) and LN involvement (HR = 3.66; 95% CI, 1.42–9.45). Patients presenting with zero, one and two risk factors had 3-year survival rates of 85, 31 and 0%, respectively, and median overall survival of 80, 22 and 13 months, respectively (p < 0.0001).

Conclusions

After I-GBC discovery following an LC, T3 tumours and tumours with LN+ are characterised by poor prognosis. The presence and the identification of these prognostic factors help identify patients in need of alternative perioperative treatments.
Literatur
1.
Zurück zum Zitat Duffy A, Capanu M, Abou-Alfa GK et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485–489.CrossRefPubMed Duffy A, Capanu M, Abou-Alfa GK et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485–489.CrossRefPubMed
2.
Zurück zum Zitat Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg. 1994;219:275–280.CrossRefPubMedPubMedCentral Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg. 1994;219:275–280.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Fuks D, Regimbeau JM, Le Treut YP et al. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg. 2011;5:1887–1897.CrossRef Fuks D, Regimbeau JM, Le Treut YP et al. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg. 2011;5:1887–1897.CrossRef
5.
Zurück zum Zitat Ethun CG, Postlewait LM, Le N, et al.Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium. JAMA Surg. 2017;152:143–149.CrossRefPubMedPubMedCentral Ethun CG, Postlewait LM, Le N, et al.Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium. JAMA Surg. 2017;152:143–149.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ethun CG, Postlewait LM, Le N, et al. A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol. 2017;24:1343–1350.CrossRefPubMed Ethun CG, Postlewait LM, Le N, et al. A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol. 2017;24:1343–1350.CrossRefPubMed
7.
Zurück zum Zitat Creasy JM, Goldman DA, Gonen M et al. Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratificatioor Modified Treatment Strategies. J Gastrointest Surg. 2017 May 8. Creasy JM, Goldman DA, Gonen M et al. Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratificatioor Modified Treatment Strategies. J Gastrointest Surg. 2017 May 8.
8.
Zurück zum Zitat Vinuela E, Vega EA, Yamashita S et al. Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High and Low-Incidence Countries. Ann Surg Oncol. 2017 Aug;24(8):2334–2343.CrossRefPubMed Vinuela E, Vega EA, Yamashita S et al. Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High and Low-Incidence Countries. Ann Surg Oncol. 2017 Aug;24(8):2334–2343.CrossRefPubMed
9.
Zurück zum Zitat Fuks D, Regimbeau JM, Pessaux P et al.Is port-site resection necessary in the surgical management of gallbladder cancer? J Visc Surg. 2013;150(4):277–84.CrossRefPubMed Fuks D, Regimbeau JM, Pessaux P et al.Is port-site resection necessary in the surgical management of gallbladder cancer? J Visc Surg. 2013;150(4):277–84.CrossRefPubMed
10.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Rahbari NN, Garden OJ, Padbury R et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–24.CrossRefPubMed Rahbari NN, Garden OJ, Padbury R et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–24.CrossRefPubMed
12.
Zurück zum Zitat Narita M, Oussoultzoglou E, Chenard MP et al.Predicting early intrahepatic recurrence after curative resection of colorectal liver metastases with molecular markers. World J Surg. 2015;39(5):1167–76.CrossRefPubMed Narita M, Oussoultzoglou E, Chenard MP et al.Predicting early intrahepatic recurrence after curative resection of colorectal liver metastases with molecular markers. World J Surg. 2015;39(5):1167–76.CrossRefPubMed
13.
Zurück zum Zitat Birnbaum DJ, Viganò L, Ferrero A, Langella S, Russolillo N, Capussotti L. Locally advanced gallbladder cancer: which patients benefit from resection? Eur J Surg Oncol. 2014;40(8):1008–15.CrossRefPubMed Birnbaum DJ, Viganò L, Ferrero A, Langella S, Russolillo N, Capussotti L. Locally advanced gallbladder cancer: which patients benefit from resection? Eur J Surg Oncol. 2014;40(8):1008–15.CrossRefPubMed
14.
Zurück zum Zitat Clemente G, Nuzzo G, De Rose AM et al. Unexpected gallbladder cancer after laparoscopic cholecystectomy for acute cholecystitis: a worrisome picture. J Gastrointest Surg. 2012;16(8):1462–8.CrossRefPubMed Clemente G, Nuzzo G, De Rose AM et al. Unexpected gallbladder cancer after laparoscopic cholecystectomy for acute cholecystitis: a worrisome picture. J Gastrointest Surg. 2012;16(8):1462–8.CrossRefPubMed
15.
Zurück zum Zitat Muratore A, Amisano M, Viganò L et al.Gallbladder cancer invading the perimuscular connective tissue: results of reresection after prior non-curative operation. J Surg Oncol. 2003;83(4):212–5.CrossRefPubMed Muratore A, Amisano M, Viganò L et al.Gallbladder cancer invading the perimuscular connective tissue: results of reresection after prior non-curative operation. J Surg Oncol. 2003;83(4):212–5.CrossRefPubMed
16.
Zurück zum Zitat D'Angelica M, Dalal KM, DeMatteo RP et al.Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16(4):806–16.CrossRefPubMed D'Angelica M, Dalal KM, DeMatteo RP et al.Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16(4):806–16.CrossRefPubMed
17.
Zurück zum Zitat Birnbaum DJ, Viganò L, Russolillo N, Langella S, Ferrero A, Capussotti L Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio. Ann Surg Oncol. 2015;22(3):811–8.CrossRefPubMed Birnbaum DJ, Viganò L, Russolillo N, Langella S, Ferrero A, Capussotti L Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio. Ann Surg Oncol. 2015;22(3):811–8.CrossRefPubMed
18.
Zurück zum Zitat Vega EA, Vinuela E, Yamashita S et al. Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status. J Gastrointest Surg. 2017 Jul 27. Vega EA, Vinuela E, Yamashita S et al. Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status. J Gastrointest Surg. 2017 Jul 27.
19.
Zurück zum Zitat Valle J, Wasan H, Palmer DH et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–81.CrossRefPubMed Valle J, Wasan H, Palmer DH et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–81.CrossRefPubMed
20.
Zurück zum Zitat Kasumova GG, Tabatabaie O, Najarian RM et al Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy. Ann Surg. 2017;266(4):625–631.CrossRefPubMed Kasumova GG, Tabatabaie O, Najarian RM et al Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy. Ann Surg. 2017;266(4):625–631.CrossRefPubMed
Metadaten
Titel
Incidental Gallbladder Carcinoma Discovered after Laparoscopic Cholecystectomy: Identifying Patients Who will Benefit from Reoperation
verfasst von
Pietro Addeo
Leonardo Centonze
Andrea Locicero
François Faitot
Hissam Jedidi
Emanuele Felli
Pascal Fuchshuber
Philippe Bachellier
Publikationsdatum
22.12.2017
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 4/2018
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-017-3655-z

Weitere Artikel der Ausgabe 4/2018

Journal of Gastrointestinal Surgery 4/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.